Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide Contributes to Cardiac Dysfunction in Western Diet-Induced Obese Mice DOI Creative Commons
Kui Chen,

Xiaoqian Zheng,

Mingchen Feng

et al.

Frontiers in Physiology, Journal Year: 2017, Volume and Issue: 8

Published: March 21, 2017

Excessive consumption of diets high in sugars and saturated fat, frequently known as western diet (WD), may lead to obesity metabolic syndrome. Recent evidence shows that WD-induced impairs cardiac function, but the underlying mechanisms are not fully understood. Trimethylamine N-oxide (TMAO), a gut microbiota-dependent metabolite specific dietary nutrients, has emerged key contributor cardiovascular disease pathogenesis. We tested hypothesis elevated circulating TMAO levels contribute dysfunction obesity. CD1 mice were fed normal (ND) or WD, without with 1.0% 3,3-Dimethyl-1-butanol (DMB, an inhibitor trimethylamine formation) drinking water for 8 weeks. Compared ND, WD showed significant increase body weight dyslipidemia, had markedly higher plasma at end feeding protocol. Echocardiography revealed systolic diastolic function was impaired WD. DMB treatment no effects on significantly reduced prevented In addition, expression pro-inflammatory cytokines tumor necrosis factor-α interleukin IL-1β, decreased anti-inflammatory cytokine IL-10, increased interstitial fibrosis hearts, all which by treatment. Notably, also ND did alter other parameters. These results suggest increases levels, inflammation fibrosis, contributing dysfunction. Interventions reduce be novel therapeutic strategy prevention

Language: Английский

Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines DOI Creative Commons
Wuwen Feng, Hui Ao, Cheng Peng

et al.

Frontiers in Pharmacology, Journal Year: 2018, Volume and Issue: 9

Published: Nov. 23, 2018

As an important source for traditional medical systems such as Ayurvedic medicine and Chinese medicine, herbal medicines have received a lot of attention all over the world, especially in developing countries. Over past decade, studies on gut microbiota generated rich information understanding how shape functioning our body system. In view importance microbiota, researchers engaged studying paid more to metabolites. Of variety metabolites, short-chain fatty acids (SCFAs) most because their role maintaining hemostasis hosts recovery diseases. Herbal medicines, resource provider production SCFAs, been demonstrated be able modulate composition regulate SCFAs production. this mini-review, we summarize current knowledge about origination, health disease, influence corresponding mechanisms. At end review, strategies suggestions further research are also discussed.

Language: Английский

Citations

303

Gut barrier disruption and chronic disease DOI
Jan Martel, Shih-Hsin Chang,

Yun‐Fei Ko

et al.

Trends in Endocrinology and Metabolism, Journal Year: 2022, Volume and Issue: 33(4), P. 247 - 265

Published: Feb. 9, 2022

Language: Английский

Citations

299

Next generation probiotics in disease amelioration DOI Creative Commons
Chih‐Jung Chang,

Tzu-Lung Lin,

Yu‐Ling Tsai

et al.

Journal of Food and Drug Analysis, Journal Year: 2019, Volume and Issue: 27(3), P. 615 - 622

Published: Feb. 2, 2019

Studies on the role of gut commensal bacteria in health development have rapidly attracted much more attention beyond classical pathogens over last decade. Many important reports highlighted changes microbiota (dysbiosis) are closely related to intra- and extra-intestinal, chronic inflammation diseases such as colitis, obesity/metabolic syndromes, diabetes mellitus, liver diseases, cardiovascular also cancer neurodegenerative diseases. To circumvent these difficulties, strategy modulating structure has been under intensive study shed light amelioration While traditional probiotics generally show marginal ameliorative effects, emerging next generation start reveal new preventive therapeutic tools. Recent studies unraveled many potential (NGP). These include Prevotella copri Christensenella minuta that control insulin resistance, Parabacteroides goldsteinii, Akkermansia muciniphila Bacteroides thetaiotaomicron reverse obesity Faecalibacterium prausnitzii protects mice against intestinal fragilis reduces shows anticancer effect. New agents will soon be revealed for targeted therapy specific The roles normobiosis maintenance integrity homeostasis emphasized.

Language: Английский

Citations

297

Dietary fucoidan modulates the gut microbiota in mice by increasing the abundance ofLactobacillusandRuminococcaceae DOI
Qingsen Shang, Xindi Shan, Chao Cai

et al.

Food & Function, Journal Year: 2016, Volume and Issue: 7(7), P. 3224 - 3232

Published: Jan. 1, 2016

Recently, fucoidan has been proposed as a potential prebiotic agent for functional food and pharmaceutical development. However, while previous studies illustrated favorable modulations of gut microbiota by fucoidan, changes in the overall microbial structure remain elusive. In present study, different fucoidans were studied using high throughput sequencing bioinformatics analysis. We found that at expense opportunistic pathogenic bacteria such Peptococcus, abundance beneficial including Lactobacillus Ruminococcaceae was significantly increased response to treatment. Besides, maintaining more balanced composition microbiota, dietary also reduced antigen load inflammatory host evidenced decreased serum lipopolysaccharide-binding protein levels. Collectively, our results indicate can be used modulator health promotion treatment intestinal dysbiosis.

Language: Английский

Citations

295

Understanding the Molecular Mechanisms of the Interplay Between Herbal Medicines and Gut Microbiota DOI
Jun Xu, Hubiao Chen, Song‐Lin Li

et al.

Medicinal Research Reviews, Journal Year: 2017, Volume and Issue: 37(5), P. 1140 - 1185

Published: Jan. 4, 2017

Herbal medicines (HMs) are much appreciated for their significant contribution to human survival and reproduction by remedial prophylactic management of diseases. Defining the scientific basis HMs will substantiate value promote modernization. Ever-increasing evidence suggests that gut microbiota plays a crucial role in HM therapy complicated interplay with components. This includes such activities as: biotransforming chemicals into metabolites harbor different bioavailability bioactivity/toxicity from precursors; improving composition microbiota, consequently ameliorating its dysfunction as well associated pathological conditions; mediating interactions (synergistic antagonistic) between multiple HMs. More advanced experimental designs recommended future study, overall chemical characterization microbiota-metabolized HMs, direct microbial analysis HM-targeted precise research model development. The outcomes can further elucidate thereby opening new window defining guiding HM-based drug discovery.

Language: Английский

Citations

291

Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon DOI
Cuiling Guo, Dandan Guo, Liu Fang

et al.

Carbohydrate Polymers, Journal Year: 2021, Volume and Issue: 267, P. 118231 - 118231

Published: May 20, 2021

Language: Английский

Citations

290

Rhein modulates host purine metabolism in intestine through gut microbiota and ameliorates experimental colitis DOI Creative Commons
Jiawei Wu, Zhonghong Wei, Peng Cheng

et al.

Theranostics, Journal Year: 2020, Volume and Issue: 10(23), P. 10665 - 10679

Published: Jan. 1, 2020

Background: Gut microbiota, which plays a crucial role in inflammatory bowel diseases (IBD), might have therapeutic benefits for ulcerative colitis or Crohn's disease. Targeting gut microbiota represents new treatment strategy IBD patients. Rhein is one of the main components rhubarb and exhibits poor oral bioavailability but still exerts anti-inflammatory effects some diseases. Therefore, we investigated effect rhein on studied its possible mechanisms. Methods: The chronic mouse model was induced by four rounds 2% dextran sulfate sodium (DSS) treatment. mice were treated with 50 mg/kg 100 daily, body weight, colon length, histological score, cytokines serum intestine, fecal lipocalin 2 concentration determined. Th17 cell, Th1 cell Th2 infiltration mesenteric lymph node analyzed flow cytometry. Metabolic profiles collected non-targeted metabolomics key metabolic pathways identified using MetaboAnalyst 4.0. We also assessed intestinal barrier permeability performed 16s rDNA sequencing. Lactobacillus sp. cultured, transplantation (FMT) employed to evaluate contribution microbiota. Results: could significantly alleviate DSS-induced colitis. Uric acid as modulator led decreased uric levels. determined that changed purine metabolism indirectly, while probiotic involved regulation host metabolism. resulted worsened barrier, be rescued rhein. further confirmed rhein-treated sufficient relieve FMT. Conclusion: showed modulate indirectly intestine subsequently alleviated Our study has approach clinical

Language: Английский

Citations

284

Review of the relationships among polysaccharides, gut microbiota, and human health DOI

Qianqian Song,

Yikun Wang,

L. Huang

et al.

Food Research International, Journal Year: 2020, Volume and Issue: 140, P. 109858 - 109858

Published: Nov. 3, 2020

Language: Английский

Citations

279

Blueberry polyphenols extract as a potential prebiotic with anti-obesity effects on C57BL/6 J mice by modulating the gut microbiota DOI
Xinyao Jiao, Yuehua Wang, Yang Lin

et al.

The Journal of Nutritional Biochemistry, Journal Year: 2018, Volume and Issue: 64, P. 88 - 100

Published: Aug. 10, 2018

Language: Английский

Citations

269

Immunomodulatory activities of polysaccharides from Ganoderma on immune effector cells DOI
Li Ren, Jie Zhang, Tiehua Zhang

et al.

Food Chemistry, Journal Year: 2020, Volume and Issue: 340, P. 127933 - 127933

Published: Aug. 26, 2020

Language: Английский

Citations

267